Abivax S.A. (ABVX) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Abivax S.A. (ABVX) Earnings Overview
As of July 8, 2026, Abivax S.A. (ABVX) reported trailing twelve-month net income of -$427M, reflecting -66.1% year-over-year growth. The company earned $-6.14 per diluted share over the past four quarters.
Looking at the long-term picture, ABVX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2014.
Abivax S.A. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ARRY (-$67M net income, -4.1% margin), PTGX (-$115M net income, -282.8% margin), PRTA (-$151M net income, -2520.6% margin), ABVX has comparable earnings metrics. Compare ABVX vs ARRY →
ABVX Earnings vs Peers
Earnings metrics vs comparable public companies
ABVX Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$336M | -90.7% | -$246M | $-4.65 | - | - |
| 2024 | -$176M | -19.3% | -$173M | $-2.80 | - | - |
| 2023 | -$148M | -143.2% | -$127M | $-3.43 | - | - |
| 2022 | -$61M | -43.1% | -$65M | $-3.18 | - | - |
| 2021 | -$42M | -13.1% | -$41M | $-2.75 | - | - |
| 2020 | -$38M | -22.6% | -$38M | $-2.62 | -59604.8% | -60330.2% |
| 2019 | -$31M | -93.6% | -$33M | $-2.51 | -1531700.0% | -1664800.0% |
| 2018 | -$16M | -41.0% | -$19M | $-1.55 | -87905.6% | -106155.6% |
| 2017 | -$11M | +21.6% | -$14M | $-1.13 | -112230.0% | -141500.0% |
| 2016 | -$14M | +10.3% | -$18M | $-1.47 | -11266.1% | -14359.1% |
| 2015 | -$16M | -214.1% | -$18M | $-1.64 | -37985.7% | -43464.3% |
| 2014 | -$5M | - | -$5M | $-0.73 | -36285.7% | -36100.0% |
Download Data
Export ABVX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ABVX — Frequently Asked Questions
Quick answers to the most common questions about buying ABVX stock.
What is ABVX earnings per share (EPS)?
ABVX trailing twelve-month (TTM) diluted EPS is $-6.14, reflecting -66.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is Abivax S.A.'s net income?
Abivax S.A. (ABVX) trailing twelve-month net income is $-427M as of 2025. Earnings declined -66.1% year-over-year.
Is ABVX profitable?
ABVX is not currently profitable on a TTM basis, reporting a net loss of $-427M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ABVX's earnings growth rate?
ABVX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are ABVX's profit margins?
Abivax S.A. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -135.6%.
Is ABVX growing earnings?
ABVX earnings are declining — EPS fell -66.1% year-over-year. TTM net income dropped to $-427M. This contrasts with the 5-year CAGR of N/A.
What was ABVX's best earnings year?
Abivax S.A.'s highest annual net income on record is $-5M, achieved in fiscal year 2014. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were ABVX's earnings last quarter?
ABVX's most recent reported quarter was Q4 2025. Net income was $-288M with diluted EPS of $-2.10. For a full breakdown of all quarters, see the quarterly earnings table on this page.